Metraipolis › archive › dc_43713532db29

Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System — Europe PMC PMID:41269930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41269930
DOI
10.1371/journal.pone.0337204
License (as archived)
solo-consultazione
Archived
2026-11-08T08:36:46.867Z
SHA-256 of the archived text
5ca085d0f54fa0b1c19526f5fd73856e43b32497a2bb50bfadde581ab9615edc
Stable URL of this page
https://metraipolis.com/documento/dc_43713532db29

How to cite

Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System — Europe PMC PMID:41269930 — Europe PMC (en), https://europepmc.org/article/MED/41269930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43713532db29 (Metraipolis archive dc_43713532db29, sha256 5ca085d0f54fa0b1c19526f5fd73856e43b32497a2bb50bfadde581ab9615edc)
BibTeX
@misc{dc43713532db29,
  title = {Safety profile of metformin in adolescents with type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System — Europe PMC PMID:41269930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41269930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43713532db29; sha256 5ca085d0f54fa0b1c19526f5fd73856e43b32497a2bb50bfadde581ab9615edc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41269930. Agents can read the archived copy with the MCP tool read_document.